A Bioequivalence Study to Compare the Pharmacokinetics of Two Betrixaban Formulations
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
This is a single center open label randomized 4-period 2-sequence replicated crossover design
study. A total of 52 healthy subjects will be randomized.